Clinically Demonstrable Anti-Autoimmunity Mediated by Allogeneic Immune Cells Favorably Affects Outcome After Stem Cell Transplantation in Human Autoimmune Diseases

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1703686
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immune-Mediated Complications After Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

The Innate Immune Sensor Sting Promotes CD8+ T Cell-Mediated GVHD After Preclinical Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Herpesvirus-Associated Central Nervous System Diseases After Allogeneic Hematopoietic Stem Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Management of Refractory Autoimmune Hemolytic Anemia After Allogeneic Hematopoietic Stem Cell Transplantation: Current Perspectives

Journal of Blood Medicine
Hematology
2019English

Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation.

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Effect of Total Nucleated and CD34+ Cell Dose on Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Kaposi's Sarcoma Developed After Allogeneic Hematopoietic Stem Cell Transplantation

Oncology Letters
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy